Please Call For More Information

LifeSolutionsPlus header image

India’s drug pricing regulator clamps down on drug cocktails

– Posted in: News

An international news website reports that an Indian drug regulatory agency has asked sixty five national and international companies why they have been selling 300 types of drugs without government approval. Most of the drugs are used to treat diabetes and infections. They are mostly cocktail, or combination drugs. The companies include well known American firms. Indian law requires government approval for drug sales. It is suspected the companies have broken the law. The agency expects to take action after June 15.

Read more: India’s drug pricing regulator clamps down on drug cocktails

0 comments… add one

Related Posts

0 comments… add one

Leave a Comment